Login / Signup

A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects.

Chaoying HuWanling SunYuanyuan WuJunlong HuangXiangrong ZhangLan Zhang
Published in: Clinical therapeutics (2024)
clinicaltrials.gov identifier: NCT03657238.
Keyphrases
  • open label
  • drug delivery
  • randomized controlled trial
  • clinical trial